Myocarditis following mRNA vaccine
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, ein Teil von Springer Nature..
This article presents the case of a 15-year-old adolescent presenting with myocarditis 4 days after receiving the 2nd dose of BNT162b2 mRNA vaccine (Comirnaty®) with no other identifiable cause. The main clinical symptom at presentation was chest pain. We found an elevated level of Troponin‑I with preserved left ventricular systolic function. The cardiac MRI showed a clear pathologic result. With symptomatic therapy and strict bed rest, the symptoms resolved quickly and revealed a mild course.
| Errataetall: |
CommentIn: Wien Med Wochenschr. 2023 Mar;173(3-4):62. - PMID 35476160 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:173 |
|---|---|
| Enthalten in: |
Wiener medizinische Wochenschrift (1946) - 173(2023), 7-8 vom: 08. Mai, Seite 192-197 |
| Sprache: |
Deutsch |
|---|
| Weiterer Titel: |
Myokarditis nach mRNA-Impfung |
|---|
| Beteiligte Personen: |
Formanek, Anna [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
BNT162 Vaccine |
|---|
| Anmerkungen: |
Date Completed 01.05.2023 Date Revised 13.12.2023 published: Print-Electronic CommentIn: Wien Med Wochenschr. 2023 Mar;173(3-4):62. - PMID 35476160 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10354-022-00959-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM345580168 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM345580168 | ||
| 003 | DE-627 | ||
| 005 | 20231227130913.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s10354-022-00959-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1225.xml |
| 035 | |a (DE-627)NLM345580168 | ||
| 035 | |a (NLM)36040634 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 100 | 1 | |a Formanek, Anna |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Myocarditis following mRNA vaccine |
| 246 | 3 | 3 | |a Myokarditis nach mRNA-Impfung |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.05.2023 | ||
| 500 | |a Date Revised 13.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Wien Med Wochenschr. 2023 Mar;173(3-4):62. - PMID 35476160 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, ein Teil von Springer Nature. | ||
| 520 | |a This article presents the case of a 15-year-old adolescent presenting with myocarditis 4 days after receiving the 2nd dose of BNT162b2 mRNA vaccine (Comirnaty®) with no other identifiable cause. The main clinical symptom at presentation was chest pain. We found an elevated level of Troponin‑I with preserved left ventricular systolic function. The cardiac MRI showed a clear pathologic result. With symptomatic therapy and strict bed rest, the symptoms resolved quickly and revealed a mild course | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID19 | |
| 650 | 4 | |a Chest pain | |
| 650 | 4 | |a Elevated level of Troponin | |
| 650 | 4 | |a Myocarditis | |
| 650 | 4 | |a mRNA vaccine | |
| 650 | 7 | |a BNT162 Vaccine |2 NLM | |
| 650 | 7 | |a Vaccines, Synthetic |2 NLM | |
| 650 | 7 | |a mRNA Vaccines |2 NLM | |
| 700 | 1 | |a Wagner, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Newrkla, Stephan |e verfasserin |4 aut | |
| 700 | 1 | |a Kurz, Herbert |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Wiener medizinische Wochenschrift (1946) |d 1946 |g 173(2023), 7-8 vom: 08. Mai, Seite 192-197 |w (DE-627)NLM00003598X |x 1563-258X |7 nnns |
| 773 | 1 | 8 | |g volume:173 |g year:2023 |g number:7-8 |g day:08 |g month:05 |g pages:192-197 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10354-022-00959-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 173 |j 2023 |e 7-8 |b 08 |c 05 |h 192-197 | ||